Reduced bone mineral density in HIV-positive individuals
- 1 September 2001
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 15 (13), 1731-1733
- https://doi.org/10.1097/00002030-200109070-00019
Abstract
A total of 105 HIV-positive patients underwent dual-energy X-ray absorbtiometry (DEXA) scan to assess bone mineral density (BMD). The prevalence of reduced BMD was found to be 71% and was higher in patients who had ever been treated with protease inhibitors (PI). Our results suggest a possible association between PI and reduced BMD, and further complicate the debate regarding when to commence treatment of HIV and with what agents to start.Keywords
This publication has 8 references indexed in Scilit:
- Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapyAIDS, 2000
- Symptomatic osteoporosis in two young HIV-positive African womenAIDS, 1999
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- HIV-1 protease inhibitors. A review for cliniciansJAMA, 1997
- Bone remodelling in human immunodeficiency virus-1-infected patients. A histomorphometric studyBone, 1995
- Screening for OsteoporosisAnnals of Internal Medicine, 1990